Isoniazid is one of the most important antibiotics used to treat and prevent tuberculosis (TB). It has been a cornerstone of TB therapy since 1952 and remains on the World Health Organization’s List of Essential Medicines, where it has appeared since 1977. Whether you’ve been prescribed isoniazid for an active TB infection or to prevent a latent infection from becoming active, here’s what you need to know about how it works, what to expect, and what to watch for.
How Isoniazid Works
Tuberculosis bacteria are surrounded by a thick, waxy outer layer made of fatty molecules called mycolic acids. This coating is what makes TB so difficult for the immune system to fight and why the bacteria can survive inside the body for years. Isoniazid shuts down the bacteria’s ability to build that protective coating.
In lab studies, actively growing TB bacteria exposed to isoniazid completely lose their ability to produce mycolic acids within 60 minutes. Without this coating, the bacterial cell wall falls apart and the bacteria die. This mechanism is highly specific to TB and closely related bacteria, which is why isoniazid doesn’t work against other types of infections.
What Isoniazid Treats
Isoniazid is used in two main situations: treating active TB disease and treating latent TB infection. Active TB means the bacteria are multiplying and causing symptoms like a persistent cough, fever, night sweats, and weight loss. Latent TB means the bacteria are in your body but dormant, not causing symptoms and not contagious. About 5 to 10 percent of people with untreated latent TB will eventually develop active disease, so treatment aims to eliminate the bacteria before that happens.
For active TB, isoniazid is always used in combination with other antibiotics. It is never used alone for active disease because TB bacteria can quickly develop resistance to a single drug. For latent TB, isoniazid can be used on its own for 6 to 9 months of daily treatment. However, the CDC now preferentially recommends shorter combination regimens lasting 3 to 4 months, using isoniazid paired with another antibiotic, because shorter courses are easier to complete. Isoniazid-only regimens are still used when those shorter options aren’t feasible, such as when other medications a person takes would interact with the companion drugs.
Liver Effects: The Most Serious Risk
The biggest concern with isoniazid is liver damage. Mild, temporary elevations in liver enzymes show up in 10 to 20 percent of people taking the drug. In most cases these resolve on their own without stopping treatment. Severe liver injury, however, occurs in roughly 1 percent of patients and requires immediately stopping the medication.
The risk of serious liver problems climbs with age. For people under 20, severe hepatitis is rare, occurring in fewer than 1 in 1,000 patients. In the 35 to 49 age group, the rate rises to about 12 per 1,000. It peaks at 23 per 1,000 among those aged 50 to 64, then drops slightly in people over 65. Because of this age-related pattern, your provider will likely monitor your liver function with blood tests during treatment, particularly if you’re over 35. If you develop symptoms like nausea, unusual fatigue, dark urine, or yellowing of the skin or eyes, those are signs to report right away.
Nerve Damage and Vitamin B6
Peripheral neuropathy, a tingling or numbness that typically starts in the hands and feet, is the most common nervous system side effect of isoniazid. It happens because the drug interferes with how your body uses vitamin B6 (pyridoxine), which is essential for nerve function. The reported incidence is low, under 0.2 percent in clinical studies, but certain groups face higher risk: people with diabetes, kidney disease, HIV, malnutrition, or alcohol use disorders.
To prevent this, a daily supplement of 10 to 25 mg of vitamin B6 is routinely recommended alongside isoniazid. This is a simple, inexpensive step that significantly reduces the chance of nerve-related problems. If you’re prescribed isoniazid and your provider doesn’t mention B6, it’s worth asking about.
Other Side Effects
Beyond the liver and nerve effects, isoniazid can cause gastrointestinal symptoms like nausea, stomach discomfort, and loss of appetite. Some people develop a skin rash or itching. These reactions are generally mild and temporary.
A less common effect is drug-induced lupus, reported in up to 1 percent of patients. This autoimmune-like reaction can cause joint pain, fever, and skin changes. It typically resolves after the medication is stopped.
Drug Interactions to Know About
Isoniazid slows down certain liver enzymes responsible for breaking down other medications. This means several common drugs can build up to higher-than-expected levels in your blood when taken alongside isoniazid. The most clinically significant interactions involve seizure medications like phenytoin, carbamazepine, and primidone, where blood levels can increase enough to cause toxicity. Sedatives like diazepam and triazolam are also affected, with their effects lasting longer than usual.
Acetaminophen (the active ingredient in Tylenol) deserves special attention. Isoniazid can alter how your body processes acetaminophen in ways that may increase the risk of liver damage from both drugs together. Warfarin, a blood thinner, may also be affected. If you take any of these medications regularly, your provider will need to adjust doses or monitor you more closely.
Pregnancy and Breastfeeding
Isoniazid is considered compatible with both pregnancy and breastfeeding when TB treatment is needed. The amount that passes into breast milk is low, and the CDC and other professional organizations state that breastfeeding should not be discouraged in women taking isoniazid. The small quantity in milk is not enough to treat or prevent TB in a nursing infant, so babies who need their own TB prevention still require a separate prescription.
Nursing mothers taking isoniazid should take 25 mg of vitamin B6 daily and can further reduce the amount their infant is exposed to by taking the daily dose just before the baby’s longest sleep period. Infants should be watched for rare signs of jaundice. In documented cases where mothers took isoniazid during pregnancy and while breastfeeding, children followed up at ages 3 to 5 were developing normally.
Why Completing Treatment Matters
One of the biggest challenges with isoniazid, particularly for latent TB, is the length of treatment. A 6- or 9-month daily regimen is a long commitment, and it’s tempting to stop once you feel fine, especially since latent TB causes no symptoms in the first place. But stopping early leaves surviving bacteria in your body, and those survivors may develop drug resistance, making any future TB infection harder to treat. Completing the full course is the single most important thing you can do to protect both yourself and the people around you.